Caliper Life Sciences Launches 'Desktop Profiler' for In-house Kinase Profiling
Caliper Life Sciences Launches 'Desktop Profiler' for In-house Kinase Profiling
Affordable, Ready-to-Use, Bench-top System Helps Therapeutic Labs Efficiently Qualify Drug Candidates
HOPKINTON, Mass., Sept. 18 // -- Caliper Life Sciences, Inc. (NASDAQ:CALP) today launched the Desktop Profiler, a bench-top system for kinase profiling, at the Society for Biomolecular Sciences (SBS) conference and exhibition in Seattle. Desktop Profiler enables therapeutic research laboratories to conduct in-house kinase profiling in a timely and cost-effective manner.
As biotech and pharmaceutical companies continue to explore the potential of kinases as viable drug targets, research scientists increasingly need to understand how drug candidates interact with the hundreds of different kinase enzymes present in the human body. This "kinase profiling" is necessary to identifying potential side effects of therapeutic candidates. Historically, cost constraints have limited the ability of therapeutic laboratories to conduct in-house profiling.
Desktop Profiler provides targeted research laboratories with a simple, affordable system to rapidly profile compounds against a diverse kinase panel. To ensure ease-of-use, the Desktop Profiler works in conjunction with ProfilerPro kinase panel kits, also launched today at SBS. ProfilerPro microplates are pre-loaded with kinases, substrates and reagents, eliminating assay development and reducing experiment set-up time. Additionally, the Desktop Profiler utilizes Caliper's LabChip microfluidic-based screening technology to yield high-quality, reproducible data that helps researchers more confidently qualify drug candidates.
"The launch of the Desktop Profiler is an important part of our larger strategy to bridge in vitro and in vivo experimentation and enhance the clinical relevancy of drug discovery and development -- for all researchers," said Kevin Hrusovsky, president and CEO of Caliper Life Sciences. "The Desktop Profiler generates meaningful in vitro data to identify drug candidates that won't drop out during in vivo studies."
The Desktop Profiler and ProfilerPro kinase panel profiling kits will be available in November. The Desktop Profiler is currently on display at the 12th annual Society for Biomolecular Sciences conference and exhibition in Seattle. For additional information, please visit Caliper Life Sciences at booth 607 or attend Caliper's press briefing on Monday, September 18 at 1:00 p.m., room 304, Washington State Convention Center.
About Caliper Life Sciences
Caliper Life Sciences is a leading provider of drug discovery and life sciences research solutions for the pharmaceutical and biotechnology industries. With its recent acquisitions of NovaScreen Biosciences and Xenogen Corporation, Caliper has positioned itself to transform drug discovery and development through a keen focus on clinically relevant experimentation. Caliper's products and services, assembled from a leading portfolio of microfluidics, liquid handling, and imaging technologies, span in vitro and in vivo experimentation and address key issues on the critical path of drug discovery and development. More information about Caliper can be found at www.caliperLS.com.
Caliper and LabChip are registered trademarks and Desktop Profiler and ProfilerPro are trademarks of Caliper Life Sciences, Inc.
Source: Caliper Life Sciences, Inc.
CONTACT: Michele Boudreau of Caliper Life Sciences, +1-650-279-2088 or michele.boudreau@caliperLS.com
Web site: www.caliperls.com/
